Skip to content
The Nexus
DossierENTITY

gray market

Coverage of gray market in the Nexus archive.

Earliest in view: Jun 26 · 11:00 UTCMost recent: Jun 26 · 11:00 UTC
Co-mentioned in this coverage
FDAorganization1Food and Drug Administrationorganization1peptidestopic1US compounding pharmaciesorganization1
Recent coverage
  • HEALTHJun 26 · 11:00 UTCGUARDIAN US
    FDA to discuss easing restrictions on peptides despite safety concerns

    The FDA will hold a meeting in July to discuss easing restrictions on research peptides, which are currently sold in a gray market with limited safety and efficacy evidence. If restrictions are relaxed, US compounding pharmacies could legally produce and fill prescriptions for these peptides.